Stockscreener 앱 받기
1.19
4.03%
-0.05
시간 외 거래:
1.22
0.03
+2.52%
전일 마감가:
$1.24
열려 있는:
$1.22
하루 거래량:
234.43K
Relative Volume:
0.03
시가총액:
$7.85M
수익:
$3,000
순이익/손실:
$-5.76M
주가수익비율:
-0.6443
EPS:
-1.8471
순현금흐름:
$-5.59M
1주 성능:
+6.25%
1개월 성능:
+46.88%
6개월 성능:
-35.33%
1년 성능:
-62.34%
1일 변동 폭
$1.19
$1.25
1주일 범위
$1.08
$1.43
52주 변동 폭
$0.62
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
명칭
Creative Medical Technology Holdings Inc
전화
480-399-2822
주소
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
1.19 | 8.44M | 3,000 | -5.76M | -5.59M | -1.8471 |
VRTX
Vertex Pharmaceuticals Inc
|
547.29 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
814.79 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,047.10 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
149.66 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
215.44 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Creative Medical Technology Holdings Inc 주식(CELZ)의 최신 뉴스
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism? - Stocktwits
CELZ Looks 171.4% Overvalued on GF Value™ - GuruFocus
CELZ Looks 142.9% Overvalued on GF Value™ - GuruFocus
Creative Medical completes enrollment in chronic back pain trial - Investing.com
Creative Medical Technology Holdings Completes Enrollment And Treatment In FDA-Cleared ADAPT Clinical Trial Evaluating CELZ-201 / Olastrocel - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Creative (CELZ) EPS and Revenue Review: The EPS Result Is Below Expectation on the Day; Market Follow-Through: The Share Price Sheds 1.82% on the DayGuidance Accuracy Score - vinanet.vn
CELZ Q2 2026 Earnings: EPS Miss of -$0.41 Reflects Pre-Revenue Pipeline InvestmentCFO Commentary Report - Vinanet
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket - Sahm
CELZ Q2 2026 Earnings: EPS Misses by 3.07% as Pre-Revenue Losses Persist; Stock Climbs 8.75%Cash Flow Report - vinanet.vn
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CELZ Jumps As New Diabetes Patent Fuels Volatile Rally - StocksToTrade
Creative Medical Technology | DEF 14A: Definitive information statements - Moomoo
Creative Medical net loss widens 22.5% to $1.51 million in Q2 2026 - Bitget
Creative Medical Technology Holdings, Inc. (CELZ) stock price, news, quote and history - Yahoo Finance Singapore
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. 2026: Revenue $0 Net income ($1.51M), EPS ($0.41) — 10-Q Summary - TradingView
Creative Medical Technology (NASDAQ: CELZ) Q2 loss, cash rises to $8.7M - Stock Titan
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Top Microcaps CELZ, PRSO, HCWC, TOON: Shorted Stocks to Watch in August 2026 - FinancialContent
Which stocks have an unusual volume on Friday? - ChartMill
Creative Medical Technology Holdings Inc (CELZ) Stock News Today - TradingKey
$Creative Medical Technology (CELZ.US)$ 小赚 - Moomoo
$Creative Medical Technology (CELZ.US)$ sky is so clear and the sun is out 🌄 - Moomoo
CELZ Stock Jumps As New Diabetes Patent Fuels Momentum - stockstotrade.com
$Creative Medical Technology (CELZ.US)$ 🫣 - Moomoo
$Creative Medical Technology (CELZ.US)$ higher timeframe dominance always - Moomoo
$Creative Medical Technology (CELZ.US)$ double dipped😋 - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Creative Medical Technology Stock Surges After Key Patent Win - Benzinga
Thursday's session: most active stocks - ChartMill
Medical Stocks To ConsiderAugust 6th - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Creative Medical receives patent allowance for diabetes exosome tech By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Shares Surge as Traders Appear to Latch Onto Earlier Pipeline Updates and a Tiny-float Setup - Moomoo
Creative Medical receives patent allowance for diabetes exosome tech - Investing.com
Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy - Yahoo Finance
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - marketscreener.com
Exosome application gets U.S. allowance to target Type 1 diabetes autoimmunity - Stock Titan
CELZ Stock Slides As Traders Track High-Volatility Setup - StocksToTrade
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
CELZ Stock Whipsaws As Traders Focus On Cash And Charts - StocksToTrade
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket - Benzinga
$Creative Medical Technology (CELZ.US)$ the timeframe i stare at all day. then higher timeframes for trend and major resistance and support areas. combine them. and you golden. - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing (Aug 3, 2026) - Stock Titan
Creative Medical Technology Holdings Inc (CELZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Creative Medical Technology Holdings (CELZ) Edges Lower Near Key Support LevelValue Factor - vinanet.vn
Creative Medical Technology Holdings Inc (CELZ) Cash Flow - TradingKey
Creative Medical Technology Holdings Inc (CELZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.43%
자본화:
|
볼륨(24시간):